By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


eXegenics Inc. (Formerly Known As Cytoclonal Pharmaceutics) 

2110 Research Row

Dallas  Texas  75235  U.S.A.
Phone: 214-358-2000 Fax: 214-350-9514



Company News
eXegenics (EXEG) Reports First Quarter 2004 Results10/19/2005 5:11:22 PM
eXegenics (EXEG) Reports Year End 2003 Results10/19/2005 5:10:50 PM
eXegenics (EXEG) Names David E. Riggs President And CEO10/19/2005 5:10:44 PM
eXegenics (EXEG) Engages BDO Seidman, LLP As New Auditor10/19/2005 5:10:32 PM
Former Nasdaq CFO Appointed To eXegenics (EXEG) Board; Gordon Martin To Serve On Audit Committee10/19/2005 5:10:28 PM
eXegenics (EXEG) Announces Dr. Ronald L. Goode Has Resigned From The Company As Chief Executive Officer And President; Quits In Dispute With Board10/19/2005 5:10:09 PM
The Nasdaq Stock Market Completes Favorable Review Of eXegenics' (EXEG) New Board; Nasdaq Staff Determines That Board And Audit Committee Are Independent10/19/2005 5:09:52 PM
eXegenics (EXEG) Release: The Nasdaq Stock Market Panel Renders Determination On Listing Of EXEG; Company Gains Extension To July To Regain Compliance10/19/2005 5:09:44 PM
eXegenics (EXEG) Announces Results Of Consent Solicitation; Five Nominees O The Meyers-Weiss Group Were Elected As Directors Of eXegenics, Replacing The Former Board Of Directors10/19/2005 5:09:28 PM
eXegenics (EXEG) Responds To Meyers-Weiss Claim10/19/2005 5:09:27 PM